David R. Harder
- Biochemistry top 0.01%
- Eicosanoids and Hypertension Pharmacology 89
-
- Hormonal Regulation and Hypertension 24
- Physiology top 0.2%
- Nitric Oxide and Endothelin Effects 76
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 18
- Neurology top 0.5%
- Traumatic Brain Injury and Neurovascular Disturbances 19
-
- Neuroscience and Neuropharmacology Research 23
-
- Ion channel regulation and function 19
-
- Cancer, Hypoxia, and Metabolism 16
- Co-authors
- Debebe GebremedhinWilliam B. CampbellRichard J. RomanJohn R. FalckR. J. RomanPhillip F. PrattRaymond C. KoehlerJayashree Narayanan
- Journals
- Nature (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
David R. Harder
208 papers receiving 13.6k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Biochemistry 6.6k
- Endocrinology, Diabetes and Metabolism 3.6k
- Physiology 5.5k
- Pharmacology 1.4k
- Neurology 905
Countries citing papers authored by David R. Harder
This map shows the geographic impact of David R. Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Harder more than expected).
Fields of papers citing papers by David R. Harder
This network shows the impact of papers produced by David R. Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Harder. The network helps show where David R. Harder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David R. Harder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 65 | |
| 2 | 2019 | 7 | |
| 3 | 2016 | 24 | |
| 4 | 2016 | 20 | |
| 5 | 2015 | 1 | |
| 6 | 2012 | 37 | |
| 7 | 2011 | 36 | |
| 8 | 2008 | 112 | |
| 9 | 2008 | 65 | |
| 10 | 2008 | 77 | |
| 11 | 2006 | 21 | |
| 12 | 2006 | 37 | |
| 13 | 2005 | 218 | |
| 14 | 2001 | 22 | |
| 15 | Cytochrome P450 2C is an EDHF synthase in coronary arteriesbreakdown → | 1999 | 785 |
| 16 | Structural determinants of the renal vascular response to 20-hydroxyeicosatetraenoic acid (20-HETE) | 1997 | 1 |
| 17 | 1997 | 152 | |
| 18 | 1993 | 47 | |
| 19 | 1990 | 124 | |
| 20 | Membrane mechanisms of adrenergic constriction and dilation in cat cerebral arteries | 1980 | 1 |
About David R. Harder
David R. Harder is a scholar working on Biochemistry, Physiology and Pharmacology, having authored 210 papers that have together received 13.9k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (89 papers), Nitric Oxide and Endothelin Effects (76 papers), Hormonal Regulation and Hypertension (24 papers), Neuroscience and Neuropharmacology Research (23 papers), Ion channel regulation and function (19 papers), Traumatic Brain Injury and Neurovascular Disturbances (19 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Cancer, Hypoxia, and Metabolism (16 papers). The work is most often cited by research in Biochemistry (6.6k citations), Endocrinology, Diabetes and Metabolism (3.6k citations) and Physiology (5.5k citations). David R. Harder has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Debebe Gebremedhin, William B. Campbell, Richard J. Roman, John R. Falck, R. J. Roman, Phillip F. Pratt, Raymond C. Koehler, Jayashree Narayanan, Andrew R. Lange and Rudi Busse. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.